Global Transcatheter Mitral Valve Replacement (TMVR) Market: Size & Forecasts (2016-2021) – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global
Transcatheter Mitral Valve Replacement (TMVR) Market: Size & Forecasts
(2016-2021)” report to their offering.
Currently, the global TMVR market is in early stage, but it is expected
to increase at high growth rates during the forecasted period
(2016-2021). The global TMVR market is supported by various growth
drivers, such as aging population, high number of cases of congenital
heart defects, rheumatic fever, low survival rate of surgical repair in
FMR patients, etc.
Yet, the market does faces certain challenges, such as, complexity in
design, success of repair surgery in DMR patients, high number of
patients not referred for surgery, etc.
The causes of MR disease are congenital heart disorder, rheumatic fever,
trauma, any other heart disease, radiation therapy, etc. The treatments
available for MR disease are surgical repair, drug treatment and
replacement. There are two types of MR: Degenerative MR (DMR) and
Functional MR (FMR). The DMR and FMR can further be subdivided into many
types.
There are different approaches for replacement surgery, depending upon
the type of MR disease. The TMVR market is in very early stage at this
moment, with many companies developing their TMVR devices. The
commercial TMVR devices are expected to be launched in next 2-3 years.
Companies Mentioned:

• Abbott Laboratories, Inc.
• Edward Lifesciences Corporation
• Medtronic

Key Topics Covered:
1. Executive Summary
2. Introduction
3. Global Market Analysis
4. Regional Market Analysis
5. Market Dynamics
6. Competitive Landscape
7. Company Profiling
For more information visit https://www.researchandmarkets.com/research/ptzcp2/global